Clinical trial
[S,S]-Reboxetine Add-On Trial
NCT00334685 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00334685 |
|---|---|
| Title | [S,S]-Reboxetine Add-On Trial |
| Official title | [S,S]-Reboxetine Add-On Trial: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN) Concomitantly Treated With Pregabalin. |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | [S, S]-Reboxetine + Pregabalin, Pregabalin |
| Enrollment | 136 |
| Start date | Aug 22, 2006 |
| Primary completion | Oct 4, 2007 |
| Completion | Oct 11, 2007 |
| First posted | Jun 8, 2006 |
| Last update posted | Dec 16, 2019 |
| Countries | Austria, Canada, Czechia, Germany, Italy, Latvia, Netherlands, Norway, Poland, Russia, Spain, Sweden and 4 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: